Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTL-TML-HSV for Recurrent Oral Herpes
NCT01308424Phase 2Completed
- Sponsor
- Beech Tree Labs
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of BTL-TML-COVID in Herpes Simplex Virus Infection (Oral), sponsored by Beech Tree Labs. Started Jan 2011; status: completed.
02
Drugs
BTL-TML-COVID
03
Conditions
Herpes Simplex Virus Infection (Oral)
Beyond the preview
Go deeper on NCT01308424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308424.